Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05291156
Title CAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge Strategy
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Campania Luigi Vanvitelli
Indications
Therapies
Age Groups: senior | adult
Covered Countries ITA

Additional content available in CKB BOOST